Pfizer看到投资者的兴趣在Q1收入强劲后有所增加, Pfizer saw increased investor interest after strong Q1 earnings, despite a "Hold" rating.

若干机构投资者增加了在辉瑞公司的股份,此前,在Q1收益丰厚之后,该公司超过分析家的预期,EPS为78美元,收入为146.5亿美元。 Several institutional investors have increased their holdings in Pfizer Inc., following strong Q1 earnings where the company surpassed analysts' expectations with an EPS of $0.78 and revenue of $14.65 billion. 尽管分析师保持“稳住”评级,目标价格为28.12美元,但辉瑞的收益和收入增长标志着金融健康的信号。 Pfizer's earnings and revenue growth signal financial health, despite analysts maintaining a "Hold" rating and a target price of $28.12. 该公司最近还宣布每季度每股0.43美元的红利。 The company also recently announced a quarterly dividend of $0.43 per share.